Clinical Trial Update: Multi-level Determinants of Starting ART Late: Aim 2

View source ↗

Summary

This entry reports on the Columbia University–sponsored study 'Multi-level Determinants of Starting ART Late: Aim 2', examining factors associated with late ini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Columbia University | Conditions: Human Immunodeficiency Virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) | Status: COMPLETED